‘‘(ii) the Committee on Health, Edu-
cation, Labor, and Pensions within the 
Senate; 
‘‘(iii) the Secretary; and 
‘‘(iv) officials with organizational au-
thorities, other than any such official who 
served as a member of the Board with re-
spect to the report involved. 
‘‘(B) AVAILABILITY TO PUBLIC.—The Di-
rector of NIH shall post each report under 
paragraph (2) on the Internet site of the Na-
tional Institutes of Health. 
‘‘(C) REPORT ON BOARD ACTIVITIES.—Not 
later than 18 months after the date of the en-
actment of the National Institutes of Health 
Reform Act of 2006, the Board shall submit to 
the committees specified in subparagraph (A) a 
report describing the activities of the Board. 
‘‘(f) ORGANIZATIONAL CHANGES PER RECOMMENDA-
TION OF SCIENTIFIC MANAGEMENT REVIEW BOARD.—
‘‘(1) IN GENERAL.—With respect to an official 
who has organizational authorities within the mean-
ing of subsection (e)(2)(A), if a recommendation to 
the official for an organizational change is made in 
a report under such subsection, the official shall, ex-
cept as provided in paragraph (2) of this subsection, 
make the change in accordance with the following: 
‘‘(A) Not later than 100 days after the re-
port is submitted under subsection (e)(7)(A), 
the official shall initiate the applicable public 
process required in subsection (d) toward mak-
ing the change. 
‘‘(B) The change shall be fully imple-
mented not later than the expiration of the 3-
year period beginning on the date on which 
such process is initiated. 
‘‘(2) OBJECTION BY DIRECTOR OF NIH.—
‘‘(A) IN
GENERAL.—Paragraph (1) does 
not apply to a recommendation for an organiza-
tional change made in a report under sub-
section (e)(2)(A) if, not later than 90 days after 
the report is submitted under subsection 
(e)(7)(A), the Director of NIH submits to the 
committees specified in such subsection a report 
providing that the Director objects to the 
change, which report includes the reasons un-
derlying the objection. 
‘‘(B) SCOPE
OF
OBJECTION.—For pur-
poses of subparagraph (A), an objection by the 
Director of NIH may be made to the entirety
of a recommended organizational change or to 
1 or more aspects of the change. Any aspect of 
a change not objected to by the Director in a 
report under subparagraph (A) shall be imple-
mented in accordance with paragraph (1). 
‘‘(g) DEFINITIONS.—For purposes of this title: 
‘‘(1) The term ‘Director of NIH’ means the Di-
rector of the National Institutes of Health. 
‘‘(2) The terms ‘national research institute’ and 
‘national center’ mean an agency of the National In-
stitutes of Health that is—
‘‘(A) listed in subsection (b) and not termi-
nated under subsection (d)(2)(A); or 
‘‘(B) established by the Director of NIH 
under such subsection. 
‘‘(h) REFERENCES TO NIH.—For purposes of this 
title, a reference to the National Institutes of Health in-
cludes its agencies.’’. 
(b) CONFORMING AMENDMENTS.—Title IV of the 
Public Health Service Act (42 U.S.C. 281 et seq.) is 
amended—
(1) by redesignating subpart 3 of part E as 
subpart 19; 
(2) by transferring subpart 19, as so redesig-
nated, to part C of such title IV;
(3) by inserting subpart 19, as so redesignated, 
after subpart 18 of such part C; and 
(4) in subpart 19, as so redesignated—
(A) by redesignating section 485B as sec-
tion 464z–1; 
(B) by striking ‘‘National Center for 
Human Genome Research’’ each place such 
term appears and inserting ‘‘National Human 
Genome Research Institute’’; and 
(C) by striking ‘‘Center’’ each place such 
term appears and inserting ‘‘Institute’’. 
SEC. 3. AUTHORITY OF DIRECTOR OF NIH. 
(a) IN GENERAL.—Section 402(b) of the Public 
Health Service Act (42 U.S.C. 282(b)) is amended—
(1) by redesignating paragraph (14) as para-
graph (22); 
(2) by striking paragraphs (12) and (13); 
(3) by redesignating paragraphs (4) through 
(11) as paragraphs (14) through (21); 
(4) in paragraph (21) (as so redesignated), by 
inserting ‘‘and’’ after the semicolon at the end; 
(5) in the matter after and below paragraph 
(22) (as so redesignated), by striking ‘‘paragraph 
(6)’’ and inserting ‘‘paragraph (16)’’; and
(6) by striking paragraphs (1) through (3) and 
inserting the following paragraphs: 
‘‘(1) shall be responsible for the overall direc-
tion of the National Institutes of Health and for the 
establishment and implementation of general policies 
respecting the management and operation of pro-
grams and activities within the National Institutes 
of Health; 
‘‘(2) shall coordinate and oversee the operation 
of the national research institutes, national centers, 
and administrative entities within the National Insti-
tutes of Health; 
‘‘(3) shall, in consultation with the heads of the 
national research institutes and national centers, be 
responsible for program coordination across the na-
tional research institutes and national centers, in-
cluding conducting priority-setting reviews, to ensure 
that the research portfolio of the National Institutes 
of Health is balanced and free of unnecessary, dupli-
cative research, and takes advantage of collaborative, 
cross-cutting research; 
‘‘(4) shall assemble accurate data to be used to 
assess research priorities, including information to 
better evaluate scientific opportunity, public health 
burdens, and progress in reducing health disparities;
‘‘(5) shall ensure that scientifically based stra-
tegic planning is implemented in support of research 
priorities as determined by the agencies of the Na-
tional Institutes of Health; 
‘‘(6) shall ensure that the resources of the Na-
tional Institutes of Health are sufficiently allocated 
for research projects identified in strategic plans; 
‘‘(7)(A) shall, through the Division of Program 
Coordination, Planning, and Strategic Initiatives—
‘‘(i) identify research that represents im-
portant areas of emerging scientific opportuni-
ties, rising public health challenges, or knowl-
edge gaps that deserve special emphasis and 
would benefit from conducting or supporting 
additional research that involves collaboration 
between 2 or more national research institutes 
or national centers, or would otherwise benefit 
from strategic coordination and planning; 
‘‘(ii) include information on such research 
in reports under section 403; and 
‘‘(iii) in the case of such research sup-
ported with funds referred to in subparagraph 
(B)—